NO995831D0 - Injiserbar, klar formulering av et anestetisk middel - Google Patents

Injiserbar, klar formulering av et anestetisk middel

Info

Publication number
NO995831D0
NO995831D0 NO995831A NO995831A NO995831D0 NO 995831 D0 NO995831 D0 NO 995831D0 NO 995831 A NO995831 A NO 995831A NO 995831 A NO995831 A NO 995831A NO 995831 D0 NO995831 D0 NO 995831D0
Authority
NO
Norway
Prior art keywords
injectable
anesthetic agent
clear formulation
formulation
clear
Prior art date
Application number
NO995831A
Other languages
English (en)
Other versions
NO995831L (no
Inventor
Vincenzo Tommaso
Original Assignee
Westy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westy Ag filed Critical Westy Ag
Publication of NO995831D0 publication Critical patent/NO995831D0/no
Publication of NO995831L publication Critical patent/NO995831L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995831A 1997-05-26 1999-11-26 Klar injiserbar formulering av en anestetisk forbindelse NO995831L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH01224/97A CH692322A5 (it) 1997-05-26 1997-05-26 Formulazione iniettabile limpida di Propofol.
PCT/EP1998/003004 WO1998053805A1 (en) 1997-05-26 1998-05-14 Clear, injectable formulation of an anesthetic compound

Publications (2)

Publication Number Publication Date
NO995831D0 true NO995831D0 (no) 1999-11-26
NO995831L NO995831L (no) 2000-01-26

Family

ID=4205400

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995831A NO995831L (no) 1997-05-26 1999-11-26 Klar injiserbar formulering av en anestetisk forbindelse

Country Status (23)

Country Link
US (1) US6326406B1 (no)
EP (1) EP0991405B1 (no)
JP (1) JP2001527577A (no)
KR (1) KR20010013011A (no)
CN (1) CN1268051A (no)
AR (1) AR012853A1 (no)
AT (1) ATE230984T1 (no)
AU (1) AU735020B2 (no)
BR (1) BR9809492A (no)
CA (1) CA2291261A1 (no)
CH (1) CH692322A5 (no)
DE (1) DE69810771D1 (no)
DZ (1) DZ2503A1 (no)
HU (1) HUP0002117A3 (no)
IN (1) IN187550B (no)
MY (1) MY132911A (no)
NO (1) NO995831L (no)
PA (1) PA8451701A1 (no)
PE (1) PE75299A1 (no)
PL (1) PL337026A1 (no)
TR (1) TR200000116T2 (no)
WO (1) WO1998053805A1 (no)
ZA (1) ZA984314B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
EP1143962B1 (en) * 1999-01-28 2004-11-24 Dinesh Shantilal Patel Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol as a solvent
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6635456B2 (en) * 2001-02-09 2003-10-21 Fidia Farmaceutici S.P.A. Procedure for the preparation of pure phosphatides with phospholipase D
US6803046B2 (en) 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
KR100482269B1 (ko) * 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
CN103405405A (zh) 2002-12-09 2013-11-27 阿布拉西斯生物科学有限责任公司 组合物和传递药剂的方法
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
JP2005154305A (ja) * 2003-11-21 2005-06-16 Showa Yakuhin Kako Kk ヒアルロン酸含有組成物の製造方法
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
KR101643416B1 (ko) 2005-08-31 2016-07-27 아브락시스 바이오사이언스, 엘엘씨 증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조방법
CA2620585C (en) 2005-08-31 2015-04-28 Abraxis Bioscience, Llc Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
EP2349309A4 (en) * 2008-11-20 2014-01-08 Teikoku Pharma Usa Inc FORMULATIONS OF PYRAZOLE DERIVATIVES
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
AU2019231699B2 (en) * 2018-03-07 2023-03-09 Andrew Xian Chen Aqueous formulations for insoluble drugs
JP7063217B2 (ja) * 2018-09-27 2022-05-09 住友電気工業株式会社 光ファイバの製造方法
JP7135670B2 (ja) * 2018-09-27 2022-09-13 住友電気工業株式会社 光ファイバ及び紫外線硬化型樹脂組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089510B (de) * 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE3221579A1 (de) * 1982-06-08 1983-12-22 Eckert, Theodor, Prof. Dr., 4400 Münster Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
AU6708096A (en) * 1995-09-18 1997-04-09 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
PL337026A1 (en) 2000-07-31
ZA984314B (en) 1998-12-08
AR012853A1 (es) 2000-11-22
PA8451701A1 (es) 2000-05-24
DZ2503A1 (fr) 2005-01-25
EP0991405B1 (en) 2003-01-15
IN187550B (no) 2002-05-18
MY132911A (en) 2007-10-31
NO995831L (no) 2000-01-26
AU735020B2 (en) 2001-06-28
EP0991405A1 (en) 2000-04-12
AU8209798A (en) 1998-12-30
BR9809492A (pt) 2000-06-20
TR200000116T2 (tr) 2000-05-22
CN1268051A (zh) 2000-09-27
HUP0002117A2 (hu) 2000-12-28
JP2001527577A (ja) 2001-12-25
CA2291261A1 (en) 1998-12-03
HUP0002117A3 (en) 2001-04-28
PE75299A1 (es) 1999-08-26
ATE230984T1 (de) 2003-02-15
US6326406B1 (en) 2001-12-04
KR20010013011A (ko) 2001-02-26
CH692322A5 (it) 2002-05-15
WO1998053805A1 (en) 1998-12-03
DE69810771D1 (de) 2003-02-20

Similar Documents

Publication Publication Date Title
NO995831D0 (no) Injiserbar, klar formulering av et anestetisk middel
NO20012915L (no) Ny farmasöytisk formulering
BR9913138B1 (pt) Derivado de quinolin-2-ona substituído com alquinila e composição farcêutica contendo o mesmo
EE9700363A (et) Uus anesteseeriva toimega farmatseutiline segu
NO952357D0 (no) Formulering av insulinanaloger
ID24654A (id) Formulasi farmasi omeprazola
DE69825982D1 (de) Spritze
PT925083E (pt) Seringas
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
PT1283051E (pt) Formulacoes de insulina estaveis
DE69711561D1 (de) Vorgefüllte Spritze
ID25533A (id) Formulasi 2-metil-tieno-benzodiazepin
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
EE200000037A (et) Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
DE69812588D1 (de) Medizinischer injektor
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
ID29294A (id) Komposisi farmasi
FI973229A0 (fi) Uusi farmaseuttinen koostumus
EE03690B1 (et) Imidasopüridasiinid, neid sisaldav ravim ja nendekasutamine
ID23928A (id) Formulasi mengandung insektisida
ID25857A (id) Komposisi farmasi
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
DE69934902D1 (de) Medikament gegen drogenabhängigkeit
NO20004816D0 (no) Ny farmasøytisk formulering

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application